Richard Peck, Global Director, Compliance & Regulatory Affairs at OnAsset [Photo: OnAsset Intelligence]
Marc Chamberlain, M.D., has been appointed as the Chief Medical Officer at Starlight Therapeutics.
Starlight Therapeutics is a Dallas-based Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options.
In his role as CMO, Chamberlain will oversee the company’s upcoming clinical trials focused on several serious and complex brain-related conditions: glioblastoma and other high-grade gliomas (aggressive types of brain tumor), brain metastases in adults (secondary brain tumors originating from cancer elsewhere in the body), and two types of pediatric brain tumors — atypical teratoid rhabdoid tumors (ATRT) and diffuse intrinsic pontine glioma (DIPG)....
Derek Beckman has been appointed chief revenue officer of Irving-based RollKall, an industry leader of innovative extra-duty law enforcement technology solutions, in a move the company said is a strategic step as the company seeks greater innovation and community impact....
Zane Burnett has joined Dallas-based Rechat, which calls itself a “super app” for real estate agents, as vice president of innovation and industry insight.
The AI-powered mobile platform for real estate was founded by serial entrepreneur Shayan Hamidi to put an agent’s digital tools all in one place....
RecNation is partnering with TowerCo to build and manage wireless towers across RecNation’s portfolio of 57 properties. [Video still: RecNation]